Back to Clinical Trials Overview
Clinical Trial Search Results: Psychiatry

Clinical Trials
Results 11 - 20 of about 80 for Psychiatry. Search took 0.04 seconds.

A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism
Principal Investigator(s): Alexander Kolevzon


A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD)
Principal Investigator(s): Alexander Kolevzon


Trichuris Suis Ova Treatment of Adult Autism Symptom Domains
Principal Investigator(s): Alexander Kolevzon


A Randomized Double-Blind Placebo-Controlled Parallel-Group Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon


Phelan-McDermid Syndrome: Insights into Synaptic Pathology and Novel Therapeutics in ASD
Principal Investigator(s): Alexander Kolevzon


Protocol H8A-MC-LZAZ(a)/ADC-040-A4 Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Principal Investigator(s): Mary Sano


Intranasal Administration of Neuropeptide Y in PTSD
Principal Investigator(s): James Murrough


Pharmacologic attenuation of ketamine using nitroprusside
Principal Investigator(s): James Murrough


Neurobiological Basis of Response to Vayarin® in Adults with ADHD: an fMRI Study of Brain Activation Pre and Post Treatment
Principal Investigator(s): Jeffrey Newcorn


A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared with OROS-MPH (CONCERTA®) with a Placebo Reference Arm, in Adolescents Aged 13-17 Years with Attention-deficit/Hyperactivity Disorder (ADHD)
Principal Investigator(s): Jeffrey Newcorn


Page  Previous   1   2   3   4   5   6   7   8   Next


Powered by Google Search Appliance